Anaferon

General characteristics. Structure:

Active components: antibodies to scale to interferon of the person affinely cleared – 0,003 g *
Excipients: lactose, cellulose microcrystallic, magnesium stearate.
* are entered in the form of aqueous-alcoholic mix of an active form of active ^{ingredient 1}

Description
Tablets of a ploskotsilindrichesky form, with risky and a facet, from white till almost white color. On the flat party from risky MATERIA MEDICA text is put, on other flat party ANAFERON text is put.

Pharmacological properties:

At preventive and medical use drug has immunomodulatory and antiviral effect. Experimentally also efficiency concerning influenza viruses (including an avian flu), a parainfluenza, viruses of a herpes simplex of 1 and 2 types (labial herpes, genital herpes), others herpes viruses (chicken pox, an infectious mononucleosis), enteroviruses, a virus of a tick-borne encephalitis, a rotavirus, a coronavirus, a kalitsivirus, adenovirus, respiratory and syncytial (PC virus) is clinically established. Drug reduces concentration of a virus in the struck fabrics, influences system of endogenous interferon and the cytokines interfaced to them, induces formation of endogenous "early" interferon (IFN а/β) and gamma interferon (IFN γ).
Stimulates a humoral and cellular immune response. Raises products of antibodies (including secretory IgA), activates functions of T-effectors, T-helperov (Тх), normalizes their ratio. Raises a functional reserve of Tkh and other cells participating in an immune response. Is the inductor of the mixed Txl and Tkh2-tipa of an immune response: increases production of Txl cytokines (IFNγ, IL-2) and Tkh2 (IL-4, 10), normalizes (modulates) balance of Tkh1/Tkh2 of activities. Increases functional activity of phagocytes and natural cells killers (EK of cells). Has anti-mutagen properties.

Indications to use:

Prevention and treatment of acute respiratory viral infections (including flu).
Complex therapy of the infections caused herpes viruses (an infectious mononucleosis, chicken pox, labial herpes, genital herpes).
Complex therapy and prevention of a recurrence of a persistent herpesviridae infection, including labial and genital herpes.
Complex therapy and prevention of other acute and persistent viral infections caused by a virus of a tick-borne encephalitis, an enterovirus, a rotavirus, a coronavirus, kalitsivirusy.
Use as a part of complex therapy of bacterial infections
Complex therapy of secondary immunodeficiency of various etiology, including prevention and treatment of complications of viral and bacterial infections.

Route of administration and doses:

Inside. On one reception – 1 tablet (to hold in a mouth before full dissolution – not during meal).
SARS, flu, intestinal infections, herpesviridae infections, neuroinfections. Treatment should be begun as soon as possible – at emergence of the first symptoms of an acute viral infection according to the following scheme: in the first 2 hours drug is accepted by each 30 minutes, then within the first days carry out three more receptions at regular intervals. From second day and further accept on 1 tablet 3 times a day to an absolute recovery.
In the absence of improvement, for the third day of treatment by drug of acute respiratory viral infections and flu - it is necessary to see a doctor.
During an epidemic season with the preventive purpose drug is accepted daily once a day within 1-3 months.
Genital herpes. At acute displays of genital herpes drug is accepted according to the following scheme at regular intervals: 1-3 day – on 1 tablet of 8 times a day, further on 1 tablet 4 times a day not less than 3 weeks.
For prevention of a recurrence of a persistent herpesviridae infection – on 1 tablet a day. The recommended duration of a preventive course is defined individually and can reach 6 months.
At the use of drug for treatment and prevention of immunodeficiency, in complex therapy of bacterial infections – to accept on 1 tablet a day.
If necessary drug can be combined with other antiviral and symptomatic means.

Features of use:

Lactose in this connection patients are not recommended to appoint it with an inborn galactosemia, a sprue of glucose or at an inborn lactose intolerance is a part of drug.

Side effects:

When using drug according to the specified indications and in the specified dosages of side effects it is not revealed.
Manifestations of the increased individual sensitivity to drug components are possible.

Interaction with other medicines:

Cases of incompatibility with other medicines are not revealed so far.
If necessary drug can be combined with other antiviral, antibacterial and symptomatic agents.

Contraindications:

The increased individual sensitivity to drug components. Drug use Anaferon children's is shown to children and persons under 18.

Pregnancy and period of a lactation
Safety of use of Anaferon for pregnant women and in the period of a lactation was not studied. In need of administration of drug it is necessary to consider a ratio risk/advantage.

Overdose:

Overdose cases are not registered so far.
At accidental overdose the dispepsichesky phenomena caused by the fillers which are a part of drug are possible.

Storage conditions:

In the dry, protected from light place, at a temperature not above 25 °C. To store in the place, unavailable to children. A period of validity - 3 years. Not to apply after a period of validity.

Issue conditions:

Without recipe

Packaging:

Tablets for a rassasyvaniye. On 20 tablets in a blister strip packaging from a film of polyvinyl chloride and aluminum foil. Each blister strip packaging together with the instruction on a medical use is placed in a pack from a cardboard.